Search Clinical Trials
Clinical Trial Listings
Volunteer
Learn About Clinical Trials

Hosu-gun, Ishikawa, Japan

Search

Location

Distance

< 2 Miles

Filters

Type

Remote

On Site

Actively recruiting

Accepts healthy volunteers

Location

Distance

< 2 Miles

< 5 Miles

< 10 Miles

< 20 Miles

< 30 Miles

< 40 Miles

< 50 Miles

Entire World

Age

0

0

Gender

Male

Female

Trial Phase

Phase 1

Phase 2

Phase 3

Phase 4

Sponsor

Celgene

Merck Sharp & Dohme Llc

Sanofi

Takeda

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids
Phase
3
Span
105 weeks
Sponsor
Sanofi
Iruma, Saitama
Recruiting
A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Phase
3
Span
106 weeks
Sponsor
Takeda
Iruma, Saitama
Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Phase
3
Span
585 weeks
Sponsor
Celgene
Iruma, Saitama
Recruiting
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)
Phase
3
Span
111 weeks
Sponsor
Sanofi
Iruma, Saitama
Recruiting
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Monotherapy Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
Phase
3
Span
139 weeks
Sponsor
Sanofi
Iruma, Saitama
Recruiting
Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension
Phase
3
Span
219 weeks
Sponsor
Merck Sharp & Dohme LLC
Iruma, Saitama
Recruiting

1-6 of 6

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 703.538.7600
Toll Free: 888.838.5578

Disclaimer
Privacy Policy
Term of Use
Do Not Sell My Personal Information